Bridging Borders: Strategies for Successful Cross-Border Participation in Global Rare Disease Clinical Trials

Approximately 300 million people worldwide are living with a rare disease. Due to the limited patient population, clinical trials for these conditions present unique considerations, particularly around recruitment and retention.

Cross-border patient participation, allowing for a broader patient pool, is a necessity. This approach can lead to additional complexities if not well-considered in advance and/or without practical experience. Key considerations include site selection, patient transportation, language and cultural barriers, differing legislation between countries, managing patient care and patient education – each of which is critical for the success of rare disease clinical trials.

In this webinar, the expert speakers will explore strategies for cross-border patient participation, drawing on lessons learned from years of experience running these trials. They will share key cross-border enrollment and retention factors for conducting these trials, covering regulatory intelligence, operational considerations and methods for enhancing patient experience.

Register for this webinar today to gain insights and strategies for success in rare disease clinical trials without boundaries.

Keywords: Rare Disease, Drug Development, Clinical Research, CRO, Patient Recruitment, Rare Diseases, Therapeutic Areas, Rare Disease Clinical Trials, Cell & Gene Therapies, Sites, Rare Disease/Orphan Drugs

Others Details

Life Sciences,Clinical Trials,Cell and Gene Therapy